Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 20727717)

1.

New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?

Seidman LJ, Nordentoft M.

Schizophr Bull. 2015 Jul;41(4):795-800. doi: 10.1093/schbul/sbv050. Epub 2015 Apr 29.

PMID:
25925393
2.

Challenges in the early detection and intervention of the psychosis-risk syndrome.

Lv H, Zhou X, Zhao J.

Shanghai Arch Psychiatry. 2015 Feb 25;27(1):45-7. doi: 10.11919/j.issn.1002-0829.215016.

3.

Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis.

Conrad AM, Lewin TJ, Sly KA, Schall U, Halpin SA, Hunter M, Carr VJ.

BMC Psychiatry. 2014 Nov 18;14:318. doi: 10.1186/s12888-014-0318-4.

4.

Informed consent in the psychosis prodrome: ethical, procedural and cultural considerations.

Morris SE, Heinssen RK.

Philos Ethics Humanit Med. 2014 Nov 18;9:19. doi: 10.1186/1747-5341-9-19. Review.

5.

To cure sometimes, to relieve often, to comfort always.

Frangou S.

Shanghai Arch Psychiatry. 2012 Dec;24(6):350-1. doi: 10.3969/j.issn.1002-0829.2012.06.007. No abstract available.

6.

Is pharmacological intervention necessary in prodromal schizophrenia?

Zhao J, Lv H, Guo X.

Shanghai Arch Psychiatry. 2012 Dec;24(6):347-9. doi: 10.3969/j.issn.1002-0829.2012.06.006. No abstract available.

7.

How should we intervene in psychosis risk syndromes?

Wang J, Jiang K, Zhang T, Li H, Woodberry K, Seidman L.

Shanghai Arch Psychiatry. 2013 Feb;25(1):6-9. doi: 10.3969/j.issn.1002-0829.2013.01.003. Review.

8.

Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers.

Koutsouleris N, Riecher-Rössler A, Meisenzahl EM, Smieskova R, Studerus E, Kambeitz-Ilankovic L, von Saldern S, Cabral C, Reiser M, Falkai P, Borgwardt S.

Schizophr Bull. 2015 Mar;41(2):471-82. doi: 10.1093/schbul/sbu078. Epub 2014 Jun 9.

PMID:
24914177
9.

Prediction and prevention of the first psychotic episode: new directions and opportunities.

Piras S, Casu G, Casu MA, Orrù A, Ruiu S, Pilleri A, Manca G, Marchese G.

Ther Clin Risk Manag. 2014 Mar 28;10:241-53. doi: 10.2147/TCRM.S55770. eCollection 2014. Review.

10.

The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ; NAPLS group.

Schizophr Bull. 2014 Nov;40(6):1452-61. doi: 10.1093/schbul/sbt235. Epub 2014 Feb 18.

PMID:
24550526
11.

DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions.

Nemeroff CB, Weinberger D, Rutter M, MacMillan HL, Bryant RA, Wessely S, Stein DJ, Pariante CM, Seemüller F, Berk M, Malhi GS, Preisig M, Brüne M, Lysaker P.

BMC Med. 2013 Sep 12;11:202. doi: 10.1186/1741-7015-11-202. Review.

12.

Working with Asian American youth at clinical high risk for psychosis: a case illustration.

Li H, Friedman-Yakoobian M, Min G, Granato AG, Seidman LJ.

J Nerv Ment Dis. 2013 Jun;201(6):484-9. doi: 10.1097/NMD.0b013e3182948084. Review.

13.
14.

Defining treatment as usual for attenuated psychosis syndrome: a survey of community practitioners.

Jacobs E, Kline E, Schiffman J.

Psychiatr Serv. 2012 Dec;63(12):1252-6. doi: 10.1176/appi.ps.201200045.

15.

The psychosis high-risk state: a comprehensive state-of-the-art review.

Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A.

JAMA Psychiatry. 2013 Jan;70(1):107-20. doi: 10.1001/jamapsychiatry.2013.269. Review.

16.

Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention.

Tandon N, Shah J, Keshavan MS, Tandon R.

Neuropsychiatry (London). 2012;2(4):345-353.

17.

Drugs for kids: good or bad?

Albert PR.

J Psychiatry Neurosci. 2012 Sep;37(5):293-5. doi: 10.1503/jpn.120140. No abstract available.

18.

Ultra high risk of psychosis on committal to a young offender prison: an unrecognised opportunity for early intervention.

Flynn D, Smith D, Quirke L, Monks S, Kennedy HG.

BMC Psychiatry. 2012 Aug 3;12:100. doi: 10.1186/1471-244X-12-100.

19.

The characteristics and activities of child and adolescent mental health services in Italy: a regional survey.

Pedrini L, Colasurdo G, Costa S, Fabiani M, Ferraresi L, Franzoni E, Masina F, Moschen R, Neviani V, Palazzi S, Parisi R, Parmeggiani A, Preti A, Ricciutello C, Rocchi MB, Sisti D, Squarcia A, Trebbi S, Turchetti D, Visconti P, Tullini A, de Girolamo G; PREMIA Group.

BMC Psychiatry. 2012 Jan 30;12:7. doi: 10.1186/1471-244X-12-7.

20.

At issue: Cochrane, early intervention, and mental health reform: analysis, paralysis, or evidence-informed progress?

McGorry P.

Schizophr Bull. 2012 Mar;38(2):221-4. doi: 10.1093/schbul/sbr185. Epub 2012 Jan 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk